VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
General Dynamics Corporation vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
General Dynamics Corporation
GD · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into General Dynamics Corporation's moat claims, evidence, and risks.
View GD analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: General Dynamics Corporation leads (80 / 100 vs 74 / 100 for Sanofi).
- Segment focus: General Dynamics Corporation has 4 segments (30.1% in Marine Systems (Nuclear subs + surface shipbuilding)); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Duopoly vs Oligopoly. Pricing power: Weak vs Moderate.
- Moat breadth: General Dynamics Corporation has 11 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
General Dynamics Corporation
Marine Systems (Nuclear subs + surface shipbuilding)
U.S. Navy nuclear-powered submarine construction and major surface combatant shipbuilding/lifecycle services
United States
Government (primarily U.S. Navy)
Prime contractor / shipbuilder / lifecycle services
30.1%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
General Dynamics Corporation strengths
Sanofi strengths
Segment mix
General Dynamics Corporation segments
Full profile >Aerospace (Gulfstream + Jet Aviation)
Oligopoly
Marine Systems (Nuclear subs + surface shipbuilding)
Duopoly
Combat Systems (Land vehicles + munitions)
Oligopoly
Technologies (C5ISR + Federal IT)
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.